Bottom line
SHISX vs SWHFX: the short answer
SHISX (Blackrock Health Sciences Opportunities Portfolio) and SWHFX (Schwab Health Care Fund) are both mutual funds.
SWHFX is cheaper at 0.8% vs 1.16% — a difference of $36 a year per $10,000 invested.
Over five years, SWHFX returned +6.5% a year vs +5.5% for SHISX.
Updated Nov 19, 2026
SHISX vs SWHFX side by side
| SHISX | SWHFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | Schwab |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.16% | 0.8% |
| Annual cost per $10k | $116 | $80 |
| 10-yr cost on $10k (prospectus) | $1,409 | $990 |
| Max front load | — | — |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +15.9% | +15.9% |
| 5-yr return (annualized) | +5.5% | +6.5% |
| 10-yr return (annualized) | +9.5% | +8.1% |
| Best quarter | +17.5% | +15.3% |
| Worst quarter | −11.5% | −12.1% |
| Net assets (fund) | $5.9B | $642.3M |
| Number of holdings | 155 | 80 |
| Portfolio turnover | 49% | 41% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SHISX | SWHFX | Difference |
|---|---|---|---|
| 2025 | +15.9% | +15.9% | +0.0% |
| 2024 | +3.8% | +0.1% | +3.7% |
| 2023 | +3.5% | +0.7% | +2.9% |
| 2022 | −6.0% | −4.7% | −1.3% |
| 2021 | +11.7% | +23.3% | −11.5% |
| 2020 | +19.4% | +12.9% | +6.6% |
| 2019 | +25.3% | +17.6% | +7.6% |
| 2018 | +8.0% | +4.0% | +4.0% |
| 2017 | +24.8% | +20.2% | +4.6% |
| 2016 | −6.1% | −4.4% | −1.7% |
Source: Fund prospectus bar charts
Holdings overlap
14 of SHISX's top 25 holdings also appear in SWHFX's top 25.
| Holding | SHISX | SWHFX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 13.92% |
| Johnson & Johnson | 8.77% | 6.94% |
| Unitedhealth Group Inc | 6.10% | 4.74% |
| Merck & Company Inc | 4.94% | 4.98% |
| Gilead Sciences Inc | 4.19% | 3.24% |
| Abbvie Inc | 3.94% | 5.81% |
| Amgen Inc | 3.37% | 2.58% |
| Thermo Fisher Scientific Inc | 3.02% | 2.16% |
| Vertex Pharmaceuticals Inc | 2.74% | 1.89% |
| Danaher Corp | 2.00% | 1.47% |
| Abbott Laboratories | 1.97% | 1.60% |
| Boston Scientific Corp | 1.59% | 1.60% |
| Elevance Health Inc | 1.56% | 1.45% |
| Stryker Corp | 1.15% | 2.11% |
Source: SEC Form N-PORT
SHISX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
SWHFX top 10
- Eli Lilly & Co — 13.92%
- Johnson & Johnson — 6.94%
- AbbVie Inc — 5.81%
- Merck & Co Inc — 4.98%
- UnitedHealth Group Inc — 4.74%
- Gilead Sciences Inc — 3.24%
- Novartis AG — 2.92%
- Amgen Inc — 2.58%
- Bristol-Myers Squibb Co — 2.44%
- Medtronic PLC — 2.29%
FAQ
What is the difference between SHISX and SWHFX?
Which is cheaper, SHISX or SWHFX?
Should I own both SHISX and SWHFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.